Malaria: Clinical Trials

16 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 unknown. 16 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 116Unknown 16
Phase 24Unknown 4

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
ZY19489 + Ferroquine (FQ), Placebo - Uncomplicated Malaria, Asymptomatic Condition
Phase 1UnknownZydus Lifesciences Limited362024-08-302024-10-01
MSP3-CRM-Vac4All/ Alhydrogel® Vaccine
MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine - Malaria,Falciparum
Phase 1 / Phase 2UnknownVac4All4652023-03-272023-04-26
MSP3-CRM-Vac4All/ Alhydrogel® Malaria Vaccine
MSP3-CRM-Vac4All/ Alhydrogel® - Malaria,Falciparum
Phase 1UnknownVac4All422021-12-012023-02-28
A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults
FMP013, ALFQ - Vaccine Reaction
Phase 1UnknownU.S. Army Medical Research and Development Command462020-03-202023-01-10
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine
Sulphadoxine-pyrimethamine - Malaria
Phase 1UnknownUniversity College Hospital, Ibadan1362018-09-012018-07-26
Plasmodium Immunotherapy for Lung Cancer
Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell
Phase 1 / Phase 2UnknownState Key Laboratory of Respiratory Disease302016-06-272023-06-22
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)
Plasmodium falciparum sporozoite (PfSPZ) - Malaria
Phase 1UnknownUniversity of Oxford2002016-05-012016-05-30
Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali
Argemone mexicana - Malaria
Phase 1UnknownUniversity of Bamako242012-09-012012-10-03
Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)
Lyophilised PEBS synthetic protein (PfPEBS), Rehydragel™ HPA - Malaria
Phase 1 / Phase 2UnknownVac4All362012-05-012012-05-25
Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years
GMZ 2 vaccine (GLURP + MSP 3), Rabies vaccine - Malaria
Phase 1UnknownAfrican Malaria Network Trust302008-06-012008-11-25
Phase Ib Trial of MSP3 LSP in Children in Tanzania
MSP 3 Long Synthetic Peptide, MSP3 vaccine, Hepatitis B vaccine - Malaria
Phase 1UnknownAfrican Malaria Network Trust452007-10-012007-12-14
Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
GMZ2 (malaria vaccine), GMZ2 malaria vaccine, Verorab vaccine - Malaria
Phase 1UnknownAfrican Malaria Network Trust402007-06-012008-04-03
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Malaria vaccine AMA1 (PfAMA-1-FVO[25-545], AMA1 - Malaria
Phase 1UnknownAfrican Malaria Network Trust402007-05-012008-04-03
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
MSP 3 Long Synthetic Peptide, Hepatitis B vaccine, Hepatitis B control vaccince - Malaria
Phase 1UnknownAfrican Malaria Network Trust452007-04-012008-05-07
GMZ2-Aluminum Hydroxide Phase I, Tübingen
GMZ2 (GLURP + MSP3 Hybrid) (malaria vaccine) - Malaria
Phase 1UnknownEuropean Vaccine Initiative302006-10-012007-08-10
IPTi in Mozambican Infants for Malaria Prevention
Sulfadoxine-Pyrimethamine (Fansidar) - Malaria
Phase 1 / Phase 2UnknownHospital Clinic of Barcelona14982002-09-012006-11-16

Narrower conditions

Malaria, Falciparum (5)  ·  Asymptomatic Diseases (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Malaria, Vivax (1)

Broader conditions

Infections (16)  ·  Mosquito-Borne Diseases (16)  ·  Parasitic Diseases (16)  ·  Protozoan Infections (16)  ·  Vector Borne Diseases (16)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Aluminum Hydroxide (2)  ·  Hepatitis B Vaccines (2)  ·  Malaria Vaccines (2)  ·  fanasil, pyrimethamine drug combination (2)  ·  MSP3 protein, Plasmodium falciparum (181-276) (1)  ·  Rabies Vaccines (1)  ·  ZY-19489 (1)  ·  ferroquine (1)  ·  thrombospondin-related adhesive protein, protozoan (1)

Sponsors

African Malaria Network Trust (5)  ·  Vac4All (3)  ·  European Vaccine Initiative (1)  ·  Hospital Clinic of Barcelona (1)  ·  State Key Laboratory of Respiratory Disease (1)  ·  U.S. Army Medical Research and Development Command (1)  ·  University College Hospital, Ibadan (1)  ·  University of Bamako (1)  ·  University of Oxford (1)  ·  Zydus Lifesciences Limited (1)

Countries

Mali (4)  ·  Gabon (3)  ·  Burkina Faso (1)  ·  China (1)  ·  Germany (1)  ·  Kenya (1)  ·  Mozambique (1)  ·  Switzerland (1)  ·  Tanzania (1)  ·  United States (1)

Top investigators

Peter Kremsner, MD, PhD (3)  ·  Clara Menendez, MD, PhD (1)  ·  Dr. Deven Parmar, MD,FCP (1)  ·  Francois Spertini, MD (1)  ·  Issa Nebie, PhD (1)  ·  Issaka Sagara, MD,MSPH (1)  ·  John P Lusingu, MD, PhD (1)  ·  Jurgen Knobloch, MD (1)  ·  Mahamadou A Thera, MD MPH (1)  ·  Mahamadou Thera, MD (1)  ·  Manamadou Thera, MD (1)  ·  Martha M Lemnge, MS, PhD (1)  ·  Ming Ou-Yang, M.D. (1)  ·  Philip Bejon, MD,PhD (1)  ·  Pierre L Druilhe, MD (1)

Results publications

PMID 18419347, PMID 19607731, PMID 19855847, PMID 21829466, PMID 21931708, PMID 27577237, PMID 31803847, PMID 34264864, PMID 35073864, PMID 35835738, PMID 36055874, PMID 37309249, PMID 37310872, PMID 42086568